News
Travis Perkins plc: Refinancing completed with renewal of £375m revolving credit facility
Block Listing Six-Monthly Return
Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Custodian Property Income REIT plc: Investor Presentation via Investor Meet Company
Genel Energy PLC: Trading and operations update
Edison issues review on BlackRock Latin American IT (BRLA): Last man standing – committed to the region.
Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
Hardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Travis Perkins: Director/PDMR & PCA Shareholding
Director/PDMR Shareholding
Travis Perkins: Directorate change
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Custodian Property Income REIT plc: Disposal of Property
Cushman & Wakefield Named a 2024 Military Friendly® Top Five Employer
Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, has ranked fourth in the Top Ten 2024 Military Friendly® Employers with revenue over $5 billion for its meaningful
Form 8.3 - Apex Fundrock Limited : Re Equals Group plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
PDMR Notification & Director Shareholding
Half year trading update and notice of results
Trading Statement for the six months to 30 September 2023
UBS hires $700 million financial advisor team in Manchester, NH
UBS Wealth Management USA today announced that a four-person financial advisor team, The Hartigan Schehl Group, has joined the firm. The team is led by Financial Advisors Will Hartigan and Steve
LivaNova to Present at the Piper Sandler Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present in a fireside chat at